Pharma Tech

Alector shares up after sealing $1.27bn Roche Parkinson’s disease license deal

Oct 6, 2026, 9:59 AM

Read Full Article → Alector shares up after sealing $1.27bn Roche Parkinson’s disease license deal

Translate article text

Choose a language and wait for the translated text.

Alector’s approach combines an engineered GCase with the biotech’s blood-brain barrier delivery platform.